Pancreatic Lipase Inhibitors (CNRS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePancreatic Lipase Inhibitors (CNRS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPancreatic triacylglycerol lipase inhibitors
TargetsPancreatic triacylglycerol lipase
Therapy Area/IndicationsObesityHyperlipidemiasCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsObesityHyperlipidemiasCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A